SCHEMBL8319733

SCHEMBL8319733

O=C1CCc2c(ccc3c2OCO3)C1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 5/20 0.46
CYP2C19 P33261 5/20 0.46
CYP3A4 P08684 4/20 0.46
TSHR P16473 3/20 0.46
KDM4E B2RXH2 2/20 0.46
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
CYP2A6 P11509 1/20 0.37
MTNR1A P48039 1/20 0.36
MTNR1B P49286 1/20 0.36
TXNRD1 Q16881 1/20 0.36
TXNRD3 Q86VQ6 1/20 0.36
TXNRD2 Q9NNW7 1/20 0.36
NQO2 P16083 2/20 0.36
CYP19A1 P11511 1/20 0.35
XBP1 P17861 1/20 0.35
AOC3 Q16853 2/20 0.34
DRD2 P14416 2/20 0.34
DRD1 P21728 1/20 0.34
CYP2C9 P11712 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11336504 0.86 CYP2D6 (0.45) CYP2D6CYP2C19CYP3A4TSHRKDM4E
SCHEMBL9739386 0.79 CYP2C19 (0.43) CYP2D6CYP2C19CYP3A4TSHRKDM4E
SCHEMBL5683553 0.74 CYP2A6 (0.54) CYP2C19CYP3A4CYP2A6CYP2C9CYP1A2
SCHEMBL161389 0.71 KDM4E (0.42) CYP2D6CYP2C19CYP3A4TSHRKDM4E
SCHEMBL232442 0.70 HTR2C (0.44) CYP2D6CYP2C19CYP3A4TSHRKDM4E
SCHEMBL5008100 0.69 CYP1A2 (0.51) CYP2C19CYP3A4KDM4ECYP2A6CYP2C9
SCHEMBL6614937 0.68 KDM4E (0.44) CYP2D6CYP2C19CYP3A4KDM4EMEN1
SCHEMBL8320757 0.68 CYP2D6 (0.57) CYP2D6CYP2C19CYP3A4TSHRKDM4E
SCHEMBL5811739 0.67 DRD2 (0.42) CYP2D6CYP2C19CYP3A4TSHRKDM4E
SCHEMBL19831767 0.67 CHRNB2 (0.37) CYP2D6CYP2C19CYP3A4TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5981541-A ACRIDINE DERIVATIVES; ANTICANCER AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 1999-11-09 US disclosed
EP-0950054-A1 SUBSTITUTED HETEROCYCLES AS ANTI-TUMOR AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 1999-10-20 EP disclosed
WO-1998012181-A1 SUBSTITUTED HETEROCYCLES AS ANTI-TUMOR AGENTS RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) 1998-03-26 WO disclosed
US-4267178-A AS ANTIHYPERTENSIVE AGENTS SCIENCE UNION ET CIE, SOCIETE FRANCAISE DE RECHERCHE MED. (FR) 1981-05-12 US disclosed